Johnson & Johnson’s profits stay healthy despite sales dip

Health-care products maker Johnson & Johnson said yesterday its first-quarter profit dipped only slightly, beating Wall Street expectations, despite falling sales around the world.

The world’s most broadly based health-care company said the recession cut into consumer products sales, but the biggest drag on revenue was the stronger U.S. dollar, which pulled down overall revenue by six per cent.